• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NEUROPACE,INC NEUROPACE RNS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NEUROPACE,INC NEUROPACE RNS SYSTEM Back to Search Results
Model Number RNS-300M-K
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Wound Dehiscence (1154); Unspecified Infection (1930)
Event Date 08/29/2017
Event Type  Injury  
Manufacturer Narrative
(b)(4).On (b)(6) 2016 patient underwent his fifth routine surgery for battery replacement.At the time, the patient was implanted with three leads (2 depths and 1 strip).
 
Event Description
Neuropace was informed on (b)(6) 2017 that the patient had reported that he had fluid around the neurostimulator on (b)(6) 2017.No action was taken at that time.The patient was seen on (b)(6) 2017 and responsive stimulation was disabled on the neurostimulator, however detection remained enabled.Details regarding the reason for the programming change were not provided.On (b)(6) 2017, the rns neurostimulator was explanted to treat infection.No other details regarding the event have been provided by the center.
 
Manufacturer Narrative
(b)(4).The patient underwent a routine neurostimulator replacement in (b)(6) 2016.In (b)(6) 2016 the patient developed irritation along the incision scar, however the patient did not report this irritation to the treating center until (b)(6) 2017.When seen by the treating center in (b)(6) 2017, the patient was found to have dehiscence of the incision site resulting in exposed hardware (lead and rns neurostimulator).The patient refused antibiotic treatment for a presumed propionibacterium infection.The site presented the patient with an option of attempted scar revision (with retention of hardware) or explantation.The patient/family opted for explantation.The explant (neurostimulator and all leads) was performed on (b)(6) 2017.Treatment included a short course (2 weeks) of postoperative antibiotics, for presumed propionibacterium acnes infection as culture results were negative.Wound remained healed after antibiotic treatment was finished.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEUROPACE RNS SYSTEM
Type of Device
NEUROPACE RNS SYSTEM
Manufacturer (Section D)
NEUROPACE,INC
455 n. bernardo ave.
mountain view CA 94043
Manufacturer (Section G)
NEUROPACE,INC
455 n. bernardo ave.
mountain view CA 94043
Manufacturer Contact
ramona gonis
455 n. bernardo ave
mountain view, CA 94043
6502372788
MDR Report Key6897880
MDR Text Key87522621
Report Number3004426659-2017-00044
Device Sequence Number1
Product Code PFN
UDI-Device Identifier00855547005120
UDI-Public010085554700512017160902
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100026
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/28/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/27/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Model NumberRNS-300M-K
Device Catalogue Number1007603
Device Lot Number21647-1-1-1
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received10/31/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age44 YR
-
-